Heva is a subsidiary of Docaposte and brand of La Poste Santé & Autonomie, a key player in health data valuation. The company is dedicated to analyzing health data and offers a wide range of expertise and innovation capabilities, from generation and collection to advanced analytics and AI for clinical research and scientific expertise. With over 30 years’ experience in clinical research and health economics, Heva's team can assist in collecting and utilizing health data. They adapt to each project in an agile manner and have integrated Inadvans and Axonal Biostatem expertise to create new synergies combining medical expertise, digital trust, and ethical commitment. Heva's fields of expertise include peri-approval, late phase interventional and observational studies, field-generated insights, HEOR modeling and strategies, RWE studies, data visualization, and consulting services. The company is headquartered in France and was founded in 2005. For more information, visit their websites: https://hevaweb.com/fr and https://axonalbiostatem.com/.
There is no investment information
No recent news or press coverage available for Heva.